You are here

Article Text

Article menu
Download PDFPDF
Commentary
Carvedilol: the β-blocker of choice for portal hypertension?

https://doi.org/10.1136/gutjnl-2012-304182

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • Funding This work was supported in part by grants from the Instituto de Salud Carlos III (ISCiii), Ministerio de Economía y Competitividad (PS 09/01261). The CIBERehd is funded by the ISCiii.

    • Competing interests None.

    • Provenance and peer review Commissioned; internally peer reviewed.

    Linked Articles